"Turning to Copaxone, we have a target action date for both the 20-milligram and 40-milligram for next month. We see no reason that these dates cannot be met. We believe that all scientific questions have been resolved to FDA satisfaction and we also believe that there are no facility GMP issues that should be a barrier to approval of this ANDA."
Mylan has always said it's right around the corner for the last three years. From what I understand, they only expected the 20mg approval and then the 40mg a couple of months later.
It doesn't make sense to me so we'll see how this transpires.
News 
Market Data 
Discover 
